No, extensive research including large trials and real-world studies has not demonstrated an increased risk of pancreatic cancer with GLP-1 receptor agonist use
Metformin improves semen characteristics of oligo-terato-asthenozoospermic men with metabolic syndrome
In a separate cohort (given sample constraints), plasma levels of ( e ) leptin, (f ) adiponectin, ( g ) resistin, ( h ) Interleukin-6 (IL-6), ( i ) tumor necrosis factor alpha (TNF), and ( j ) monocyte chemoattractant protein-1 (MCP-1) were measured in Gipr fl/fl (n=8) and Gipr Syn / (n=14) mice
Medication selection should consider the patient's comorbidity profile, previous medication responses, potential drug interactions, and individual preferences
2 Strategies employed to develop GLP-1 receptor agonists with prolonged in vivo half-lives
Starting with children makes sense as it hits a core demographic of food supply / toxicity critics crunchy moms